Effect of genetic polymorphism of CYP3A5 and CYP2C19 and concomitant use of voriconazole on blood tacrolimus concentration in patients receiving hematopoietic …

T Iwamoto, F Monma, A Fujieda… - Therapeutic Drug …, 2015 - journals.lww.com
Background: Blood tacrolimus (TAC) concentration delivered via intravenous administration
is known to be influenced by genetic polymorphism of CYP3A5 and interaction with triazole …
被引用次数：38 相关文章

[引用][C] Effect of Genetic Polymorphism of CYP3A5 and CYP2C19 and Concomitant Use of Voriconazole on Blood Tacrolimus Concentration in Patients Receiving …

T Iwamoto, F Monma, A Fujieda, K Nakatani… - Therapeutic Drug …, 2015 - cir.nii.ac.jp
Effect of Genetic Polymorphism of CYP3A5 and CYP2C19 and Concomitant Use of
Voriconazole on Blood Tacrolimus Concentration in Patients Receiving Hematopoietic Stem …

Effect of Genetic Polymorphism of CYP3A5 and CYP2C19 and Concomitant Use of Voriconazole on Blood Tacrolimus Concentration in Patients Receiving …

T Iwamoto, F Monma, A Fujieda, K Nakatani… - Therapeutic Drug …, 2015 - europepmc.org
Background Blood tacrolimus (TAC) concentration delivered via intravenous administration
is known to be influenced by genetic polymorphism of CYP3A5 and interaction with triazole …

Effect of Genetic Polymorphism of CYP3A5 and CYP2C19 and Concomitant Use of Voriconazole on Blood Tacrolimus Concentration in Patients Receiving …

T Iwamoto, F Monma, A Fujieda… - Therapeutic drug …, 2015 - pubmed.ncbi.nlm.nih.gov
Background Blood tacrolimus (TAC) concentration delivered via intravenous administration
is known to be influenced by genetic polymorphism of CYP3A5 and interaction with triazole …

Effect of genetic polymorphism of CYP3a5 and CYP2C19 and concomitant use of voriconazole on blood tacrolimus concentration in patients receiving hematopoietic …

T Iwamoto, F Monma, A Fujieda, K Nakatani, AA Gayle… - 2015 - cabidigitallibrary.org
Background: Blood tacrolimus (TAC) concentration delivered via intravenous administration
is known to be influenced by genetic polymorphism of CYP3A5 and interaction with triazole …